Evidence map›Paper›PMID 29118049›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2017

The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota.

Christian Milani, Sabrina Duranti, Francesca Bottacini, Eoghan Casey, Francesca Turroni, Jennifer Mahony, Clara Belzer, Susana Delgado Palacio, Silvia Arboleya Montes, Leonardo Mancabelli and 8 more

Abstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,041 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,041citing papers in PubMed, 11 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,041 citing papers in PubMed, 11 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. A Systematic Review to Reassess the Formula for Early Life Growth.Advances in nutrition (Bethesda, Md.) · 2026
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Long-Term Efficacy ofNutrients · 2026
    Trial
  16. Trial
  17. Trial
  18. Trial
  19. Review
  20. Article

981 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Christian MilaniLaboratory of Probiogenomics, Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.
Sabrina DurantiLaboratory of Probiogenomics, Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.
Francesca BottaciniAPC Microbiome Institute and School of Microbiology, National University of Ireland, Cork, Ireland.
Eoghan CaseyAPC Microbiome Institute and School of Microbiology, National University of Ireland, Cork, Ireland.
Francesca TurroniLaboratory of Probiogenomics, Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.
Jennifer MahonyAPC Microbiome Institute and School of Microbiology, National University of Ireland, Cork, Ireland.
Clara BelzerLaboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.
Susana Delgado PalacioDepartamento de Microbiologia y Bioquimica de Productos Lacteos, IPLA-CSIC, Villaviciosa, Asturias, Spain.
Silvia Arboleya MontesDepartamento de Microbiologia y Bioquimica de Productos Lacteos, IPLA-CSIC, Villaviciosa, Asturias, Spain.
Leonardo MancabelliLaboratory of Probiogenomics, Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.
Gabriele Andrea LugliLaboratory of Probiogenomics, Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.
Juan Miguel RodriguezDepartment of Nutrition, Food Science and Food Technology, Complutense University of Madrid, Madrid, Spain.
Lars BodeDepartment of Pediatrics and Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence, University of California-San Diego, La Jolla, California, USA.
Willem de VosLaboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.
Miguel GueimondeDepartamento de Microbiologia y Bioquimica de Productos Lacteos, IPLA-CSIC, Villaviciosa, Asturias, Spain.
Abelardo MargollesDepartamento de Microbiologia y Bioquimica de Productos Lacteos, IPLA-CSIC, Villaviciosa, Asturias, Spain.
Douwe van SinderenAPC Microbiome Institute and School of Microbiology, National University of Ireland, Cork, Ireland d.vansinderen@ucc.ie marco.ventura@unipr.it.
Marco VenturaLaboratory of Probiogenomics, Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy d.vansinderen@ucc.ie marco.ventura@unipr.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human gut microbiota is engaged in multiple interactions affecting host health during the host's entire life span. Microbes colonize the neonatal gut immediately following birth. The establishment and interactive development of this early gut microbiota are believed to be (at least partially) driven and modulated by specific compounds present in human milk. It has been shown that certain genomes of infant gut commensals, in particular those of bifidobacterial species, are genetically adapted to utilize specific glycans of this human secretory fluid, thus representing a very intriguing example of host-microbe coevolution, where both partners are believed to benefit. In recent years, various metagenomic studies have tried to dissect the composition and functionality of the infant gut microbiome and to explore the distribution across the different ecological niches of the infant gut biogeography of the corresponding microbial consortia, including those corresponding to bacteria and viruses, in healthy and ill subjects. Such analyses have linked certain features of the microbiota/microbiome, such as reduced diversity or aberrant composition, to intestinal illnesses in infants or disease states that are manifested at later stages of life, including asthma, inflammatory bowel disease, and metabolic disorders. Thus, a growing number of studies have reported on how the early human gut microbiota composition/development may affect risk factors related to adult health conditions. This concept has fueled the development of strategies to shape the infant microbiota composition based on various functional food products. In this review, we describe the infant microbiota, the mechanisms that drive its establishment and composition, and how microbial consortia may be molded by natural or artificial interventions. Finally, we discuss the relevance of key microbial players of the infant gut microbiota, in particular bifidobacteria, with respect to their role in health and disease.

Indexed as

Infant HealthMaternal-Fetal ExchangeBiomarkersBreast FeedingFemaleGastrointestinal MicrobiomeGastrointestinal TractHumansImmune SystemInfantIntestinal DiseasesMilk, HumanPregnancyProbioticsSymbiosisWhole Genome SequencingBiomarkersbifidobacteriagut commensalsgut microbiotainfantsmetagenomicsmicrobiomemicrobiotaprobioticsvirome

Identifiers

PMID29118049
PMCPMC5706746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.